Results 161 to 170 of about 21,293 (203)

Clinical effectiveness of entecavir versus tenofovir disoproxil fumarate tablets in chronic hepatitis B treatment. [PDF]

Am J Transl Res
Zhou Y, Shen Y, He J, Yang X.
europepmc   +1 more source

Brief communication: comparison of changes in metabolic parameters following antiretrovial therapy with treatment regimens containing tenofovir alafenamide and tenofovir disoproxil fumarate. [PDF]

AIDS Res Ther
Mirmoezzi H, Koochak HE, Dehghan Manshadi SA, Hasannezhad M, SeyedAlinaghi S, Semnani K, Abbasian L, Ghaderkhani S.   +7 more
europepmc   +1 more source

Tenofovir disoproxil fumarate versus entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma after surgical resection: a systematic review and meta-analysis. [PDF]

Front Oncol
Wang Y, Wu JY, Xiang Q, Liao TF, Jiang XY, Chen J.   +5 more
europepmc   +1 more source

Factors predicting renal impairment associated with Tenofovir Disoproxil fumarate: Focus on patients with HIV and pre-existing metabolic abnormalities under the Thai National Health Security Scheme. [PDF]

Prev Med Rep
Duangrithi D, Silathong K.
europepmc   +1 more source

Bone loss in young adults with HIV following antiretroviral therapy containing tenofovir disoproxil fumarate regimen using machine learning. [PDF]

Front Pharmacol
Chen L, Tang J, Zhang L, Zheng L, Wang F, Guo F, Han Y, Song X, Lv W, Cao W, Li T.   +10 more
europepmc   +1 more source

Bone Mineral Density Changes in People with HIV Who had Immediate Switch Versus Deferred Switch from Tenofovir Disoproxil Fumarate-Based Regimens to Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Multicenter, Open-Label, Randomized Clinical Trial. [PDF]

Infect Dis Ther
Shao Y, Yang X, Yu J, Wang X, Wang J, Liu M, Yang Z, Han J, Zhang R, Liu L, Shen Y, Sun M, Wu L, Zheng Z, Tang Y, Yang J, Wang Z, Qi T, Xu S, Xun J, Sun J, Song W, Chen J.   +22 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Tenofovir Disoproxil Fumarate

International Journal of Toxicology, 2015
exaly   +7 more sources

Tenofovir Disoproxil Fumarate

Drugs, 2003
Tenofovir disoproxil fumarate (tenofovir DF) is a prodrug of tenofovir, a nucleotide reverse transcriptase inhibitor. In two large, well designed, placebo-controlled clinical trials, tenofovir DF 300 mg/day resulted in significant reductions in HIV-1 RNA from baseline compared with placebo at 24 weeks in antiretroviral-experienced patients with HIV ...
Therese, Chapman, Jane, McGavin, Stuart, Noble   +2 more
  +9 more sources

Tenofovir disoproxil fumarate

Reactions Weekly, 2017
  +7 more sources